[#item_full_content]”You cannot responsibly introduce products into a Medicare population when their chemistry is not fully defined and their safety cannot be established. This is not a policy debate-it’s a scientific one. MMJ followed the FDA pathway because patients deserve certainty, not guesswork.” sta…
Read More